Michael Morneau Viking Therapeutics, Inc. (VKTX) insider trading activity

VKTX Quotes by TradingView

Michael Morneau is VP, Finance and Administration of Viking Therapeutics, Inc.. Currently has a direct ownership of 116,062 shares of VKTX, which is worth approximately $4.92 Million. The most recent transaction as insider was on Jan 19, 2021, when has been sold 1,685 shares (Common stock, par value $0.00001 per share) at a price of $6.68 per share, resulting in proceeds of $11,256. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
0% 3M change
0% 12M change
Total Value Held $4.92 Million

MICHAEL MORNEAU Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2021
SELL
Payment of exercise price or tax liability
$11,256 $6.68 p/Share
1,685 Reduced 1.43%
116,062 Common stock, par valu...
Jan 04 2021
SELL
Payment of exercise price or tax liability
$15,886 $5.8 p/Share
2,739 Reduced 2.27%
117,747 Common stock, par valu...
Jan 04 2021
BUY
Grant, award, or other acquisition
-
21,334 Added 15.04%
120,486 Common stock, par valu...
MM

Michael Morneau

VP, Finance and Administration
San Diego, CA

Track Institutional and Insider Activities on VKTX

Follow Viking Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VKTX shares.

Notify only if

Insider Trading

Get notified when an Viking Therapeutics, Inc. insider buys or sells VKTX shares.

Notify only if

News

Receive news related to Viking Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VKTX